It is dangerous to conclude that reduction of omega-6 fatty acid intake and anti-PI3K inhibitors may be worth considering as future therapeutic approaches to battle prostate cancer.

208

The model using the PC3 prostate cancer cells is irrelevant. So the implications of the findings to the treatment of prostate cancer are questionable. It is dangerous to conclude that reduction of omega-6 fatty acid intake and anti-PI3K inhibitors may be worth considering as future therapeutic approaches to battle prostate cancer.

118